Detalhe da pesquisa
1.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
Lancet Oncol
; 24(10): 1119-1133, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717583
2.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eur J Nucl Med Mol Imaging
; 49(3): 932-942, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405277
3.
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Eur J Nucl Med Mol Imaging
; 49(13): 4642-4651, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925442
4.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
5.
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study.
Haematologica
; 105(6): 1650-1659, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515355
6.
Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial.
Lancet
; 391(10123): 860-869, 2018 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459021
7.
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.
Haematologica
; 104(11): 2265-2273, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948492
8.
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
Transfusion
; 59(1): 316-324, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548284
9.
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
Blood
; 127(9): 1109-16, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802176
10.
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
Blood
; 128(15): 1979-1986, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27549307
11.
Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma.
Blood
; 125(3): 449-56, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398935
12.
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System.
Blood
; 126(17): 1996-2004, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26330243
13.
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Haematologica
; 107(7): 1726-1730, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295081
14.
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Hematol Oncol
; 35(4): 497-503, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27530779
15.
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance.
Blood
; 121(4): 624-7, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23233657
16.
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.
Haematologica
; 100(5): 677-82, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661441
17.
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
Haematologica
; 105(12): 2879-2882, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256392
18.
4ß-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
Br J Clin Pharmacol
; 80(3): 560-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119961
19.
The Effect of Differentiation Grade of Cutaneous Squamous Cell Carcinoma on Excision Margins, Local Recurrence, Metastasis, and Patient Survival: A Retrospective Follow-Up Study.
Ann Plast Surg
; 75(3): 323-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401812
20.
Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.
J Stroke Cerebrovasc Dis
; 24(7): 1679-84, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934140